| Autor: |
Ana M, Denis-Bacelar, Sarah J, Chittenden, Iain, Murray, Antigoni, Divoli, V, Ralph McCready, David P, Dearnaley, Joe M, O'Sullivan, Bernadette, Johnson, Glenn D, Flux |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Physics in Medicine and Biology |
| ISSN: |
1361-6560 |
| Popis: |
Skeletal tumour burden is a biomarker of prognosis and survival in cancer patients. This study proposes a novel method based on the linear quadratic model to predict the reduction in metastatic tumour burden as a function of the absorbed doses delivered from molecular radiotherapy treatments. The range of absorbed doses necessary to eradicate all the bone lesions and to reduce the metastatic burden was investigated in a cohort of 22 patients with bone metastases from castration-resistant prostate cancer. A metastatic burden reduction curve was generated for each patient, which predicts the reduction in metastatic burden as a function of the patient mean absorbed dose, defined as the mean of all the lesion absorbed doses in any given patient. In the patient cohort studied, the median of the patient mean absorbed dose predicted to reduce the metastatic burden by 50% was 89 Gy (interquartile range: 83–105 Gy), whilst a median of 183 Gy (interquartile range: 107–247 Gy) was found necessary to eradicate all metastases in a given patient. The absorbed dose required to eradicate all the lesions was strongly correlated with the variability of the absorbed doses delivered to multiple lesions in a given patient (r = 0.98, P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
